Cultureuk Editorial Desk English (UK)
cultureuk.uk Cultureuk Editorial Desk
Blog Business Local Politics Tech World

How to Get Mounjaro on NHS: 2025 Criteria, Cost & GP Tips

Jack Oliver Cooper Howard • 2026-06-06 • Reviewed by Hanna Berg

The news that Mounjaro (tirzepatide) is available on the NHS from March 2025 has sent many people searching for a prescription from their GP. Yet the reality is more complicated: as of June 2025, GPs in England can prescribe it for weight loss, but only in a strict phased rollout that starts with patients who have a BMI of 40 or more and at least four specific weight-related conditions.

Approval start date: 23 March 2025 ⋅
Prescribing authority: Specialist weight management service only (initially) ⋅
Private availability: Yes, via pharmacies and online clinics ⋅
Brand name (active ingredient): Mounjaro (tirzepatide)

Quick snapshot

1NHS Eligibility
2GP Role
3Cost Options
4Timeline

The key facts below capture the essential details for anyone trying to understand their options.

Key facts about Mounjaro on the NHS
Field Value
NHS start date 23 March 2025
Prescribing pathway Specialist weight management service
Active ingredient Tirzepatide (Mounjaro)
NICE guideline (weight loss) Draft guidance expected 2025
NICE guideline (T2D) TA924

Can I get Mounjaro on the NHS for weight loss?

What are the NHS criteria for Mounjaro?

Yes, you can get Mounjaro on the NHS for weight loss, but only if you meet specific criteria and are referred through the correct pathway. NHS England (official guidance) states that from 23 March 2025, Mounjaro is available for weight management exclusively through a specialist weight management service. The NICE (guidance for type 2 diabetes) guideline TA924 covers its use for diabetes, but a separate draft for weight loss is still expected in 2025.

The upshot

Patients with a BMI of 40 or more and at least four weight-related conditions — such as hypertension, sleep apnoea, type 2 diabetes, cardiovascular disease, or dyslipidaemia — are first in line. Those with a BMI between 35 and 39.9 and the same conditions will be considered from June 2026.

Eligibility typically requires a BMI of at least 35 with one obesity-related condition, but exact criteria vary by region. NHS Cheshire and Merseyside provides a clear example: their Cohort 1, which started on 23 June 2025, required BMI ≥40 plus four of five specified conditions. Cohort 2, beginning 23 June 2026, widens access to BMI 35–39.9 with the same conditions, as confirmed by NHS Cheshire and Merseyside (regional health board).

The implication: national rollout is phased over up to 12 years, so there is no single waiting list. Your eligibility depends on both your clinical profile and where you live.

Can I ask my GP for Mounjaro?

What should I say to my GP to get Mounjaro?

You can ask your GP — but they almost certainly won’t prescribe it directly for weight loss. NHS England (official guidance) states that Mounjaro must be prescribed by a specialist weight management service. Your GP’s role is to assess whether you meet the criteria and, if so, refer you to that service.

Will my GP prescribe Mounjaro directly?

Not for weight loss — unless you have type 2 diabetes. Under NICE (guidance for type 2 diabetes) TA924, GPs can prescribe Mounjaro for diabetes management. For weight loss alone, Second Nature (weight management service) explains that from 23 June 2025, GP prescribing for obesity began but only within local allocation limits and for patients in the highest-need cohort.

  1. Ask your GP for a referral to a specialist weight management service. NHS (referral system) outlines the process.
  2. If you have type 2 diabetes, mention NICE TA924 — your GP may prescribe it directly. NICE (guidance page)
  3. Be prepared to share your BMI, any weight-related conditions, and your history of lifestyle interventions.

What this means: your GP is a gatekeeper to the specialist service, not a direct prescriber. If they refuse, it’s usually because the system doesn’t allow it yet — not because they don’t want to help.

How can I get Mounjaro for free?

Is Mounjaro free on the NHS?

If you meet the eligibility criteria and are prescribed Mounjaro through a specialist weight management service or a GP under the phased rollout, it is free at the point of use — just like any other NHS prescription. NHS England (official guidance) confirms that patients who qualify pay the standard NHS prescription charge (£9.90 per item in England as of 2025) or nothing if they are exempt (e.g., on benefits, over 60, or pregnant).

Why this matters

For those who don’t meet the strict NHS criteria, private prescriptions cost between £200 and £300 per month. The gap between free NHS access and private cost is enormous — and it’s why understanding the eligibility rules matters so much.

Private prescriptions are widely available now. You can access Mounjaro privately through pharmacies like Boots (pharmacy pricing), Superdrug (pharmacy portal), and online clinics such as WePrescribe (online clinic) and Oxford Online Pharmacy (online pharmacy) — but expect to pay the full private cost.

The pattern: free NHS access is limited to those who fit the narrow eligibility box, while everyone else faces a steep monthly bill.

How much is Mounjaro at Boots?

Where can I find the cheapest Mounjaro in the UK?

As of 2025, Boots (pharmacy pricing) charges approximately £299 per month for a private Mounjaro prescription. This is not the cheapest option — several online pharmacies offer more competitive prices. Superdrug (pharmacy portal) and WePrescribe (online clinic) often list private Mounjaro at £220–£260 per month.

  • Boots: ~£299/month Boots (pharmacy pricing)
  • Superdrug: ~£250/month Superdrug (pharmacy portal)
  • Online pharmacies (WePrescribe, Oxford Online): £220–£260/month WePrescribe (online clinic)

The trade-off: the lowest price may come from smaller online clinics, but you must ensure they are registered with the General Pharmaceutical Council (regulatory body) and offer genuine medical supervision.

Why won’t my GP give me Mounjaro?

What are the common reasons for rejection?

Most GPs cannot prescribe Mounjaro for weight loss because the system doesn’t allow them to — at least not yet for everyone. NHS England (official guidance) explicitly states that Mounjaro for weight management must be prescribed by a specialist weight management service, not a GP. Even from 23 June 2025, when GP prescribing began, it was limited to patients in Cohort 1 — those with a BMI of 40 or more and at least four weight-related conditions, as detailed by NHS Cheshire and Merseyside (regional health board).

Common reasons for rejection include:

  • Your BMI is below the threshold (typically under 35–40 depending on region).
  • You don’t have enough weight-related health conditions (four are required for Cohort 1).
  • Your local NHS region hasn’t yet started its phased rollout — the national plan spans up to 12 years, Second Nature (weight management service) notes.
  • Your GP prefers lifestyle interventions first, as per local commissioning rules.
The catch

Many patients are turned away not because they don’t need Mounjaro, but because their local NHS trust hasn’t expanded access yet. The system is rationed, not judgmental — but that doesn’t make the rejection any less frustrating for someone struggling with obesity.

If you’re refused, ask your GP for a referral to a specialist weight management service. If they say no, request written reasons and check whether your local ICB has published its rollout timeline.

What does the phase rollout timeline look like?

The timeline below shows the key dates in the phased NHS rollout of Mounjaro for weight loss.

Timeline signal: phased NHS rollout of Mounjaro for weight loss
Date or period Event
23 March 2025 NHS England begins prescribing Mounjaro for weight management exclusively through specialist weight management services. NHS England (official guidance)
23 June 2025 GP prescribing for obesity begins in England within local allocation limits — Cohort 1 (BMI ≥40 + 4 conditions). Second Nature (weight management service)
23 June 2026 Cohort 2: BMI 35–39.9 with 4 of 5 conditions. NHS Cheshire and Merseyside (regional health board)
1 April 2027 Cohort 3: BMI ≥40 with at least 3 of 5 conditions. NHS Cheshire and Merseyside (regional health board)

The pattern: each cohort expands access gradually, meaning patients with lower clinical urgency will wait years for NHS coverage.

Confirmed facts and what remains unclear

Confirmed facts

  • Mounjaro is available on NHS from March 2025 for weight management. NHS England (official guidance)
  • Prescription must come from a specialist weight management service initially. NHS England (official guidance)
  • GP prescribing for obesity began in June 2025 only for highest-need cohort. Second Nature (weight management service)
  • Private cost is £200–£300 per month at major pharmacies. Boots (pharmacy pricing)

What’s unclear

  • Exact regional variation in rollout — each ICB decides its own timeline.
  • Whether GPs will eventually be allowed to prescribe directly for all eligible patients.
  • Full NICE criteria for weight loss use of Mounjaro (still in draft stage).

“From 23 March 2025, you may be prescribed tirzepatide (Mounjaro) to manage your weight only if it is prescribed by a specialist weight management service.”

— NHS England (official guidance)

“Cohort 1 started on 23 June 2025 and required BMI of at least 40 plus four of five conditions: dyslipidaemia, hypertension, obstructive sleep apnoea, cardiovascular disease, and type 2 diabetes.”

— NHS Cheshire and Merseyside (regional health board)

The NHS phased rollout is a rationing mechanism, not a permanent bar. For patients who don’t qualify yet, the private route is immediate but costly. For those in Cohort 1, NHS access is now a reality — but only if your GP refers you to a specialist service or your local ICB has activated primary care prescribing.

For anyone in England awaiting access, the choice is clear: pursue a specialist referral through your GP and check your local ICB’s timeline, or explore private options with a registered pharmacy if the wait is too long.

If you meet the NHS criteria, you may be prescribed Mounjaro—for a detailed breakdown of the process, refer to the weight loss injections NHS availability guide which also covers costs and alternative options.

Frequently asked questions

What is the difference between Mounjaro and Wegovy on the NHS?

Mounjaro (tirzepatide) is a dual GLP-1/GIP receptor agonist, while Wegovy (semaglutide) targets only GLP-1. Both are available on the NHS for weight loss, but under different criteria and rollout timelines. Mounjaro’s phased NHS rollout began in March 2025, whereas Wegovy has been available longer through specialist services.

Can I get Mounjaro on the NHS if I have type 2 diabetes?

Yes. Under NICE guidance TA924, Mounjaro is recommended for type 2 diabetes, and GPs can prescribe it directly for this condition. The weight loss rollout is separate and follows different criteria.

Are there other weight loss injections available on the NHS?

Yes. Wegovy (semaglutide) and Saxenda (liraglutide) are also available on the NHS for weight management, each with their own eligibility criteria. Mounjaro is the newest addition.

How do I get a referral to a specialist weight management service?

Book an appointment with your GP and discuss your weight history, BMI, and any related health conditions. If you meet the criteria, they can refer you to your local Tier 3 weight management service.

Is Mounjaro safe for long-term weight loss?

Clinical trials show Mounjaro is effective for long-term weight management, but it should be used under medical supervision. Common side effects include nausea and diarrhoea. Discuss risks with your prescriber.

Can I use Mounjaro privately and then switch to NHS prescription?

It depends on your clinical profile and eligibility. If you later meet NHS criteria and are referred, you may be able to transfer care. There is no automatic switch mechanism — you’ll need a formal NHS assessment.

Related reading



Jack Oliver Cooper Howard

About the author

Jack Oliver Cooper Howard

Our desk combines breaking updates with clear and practical explainers.